About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Phf6tm1.1Avo
targeted mutation 1.1, Anne K Voss
MGI:6507034
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Phf6tm1.1Avo/Y
Tg(Tek-cre)1Ywa/0
involves: C57BL/6 * SJL MGI:6507173
cn2
Phf6tm1.1Avo/Y
Tg(Nes-cre)1Kln/0
involves: C57BL/6 * SJL MGI:6507211


Genotype
MGI:6507173
cn1
Allelic
Composition
Phf6tm1.1Avo/Y
Tg(Tek-cre)1Ywa/0
Genetic
Background
involves: C57BL/6 * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Phf6tm1.1Avo mutation (1 available); any Phf6 mutation (12 available)
Tg(Tek-cre)1Ywa mutation (6 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• mice show a modestly accelerated onset of spontaneous hematopoietic malignancy

hematopoietic system
• mice show perturbation in early T-cell differentiation
• percentages of double-negative precursor stage 3 (DN3) cells are reduced but their total numbers are not significantly reduced
• mice have only 58% double-negative precursor stage 2 (DN2) cells compared with controls
• however, the numbers and percentages of downstream populations are not altered in the thymus
• numbers of plasmacytoid dendritic cells are increased in the bone marrow
• within the HPC-1 population, the percentage of FLT3hi cells is increased, suggesting an increase in lymphoid-based cells
• 85% increase in the numbers of common lymphoid progenitor cells
• analysis of LSK subsets shows a reduced number of hematopoietic stem cells (HSC)
• the number of cells within the LSK stem and progenitor cell-enriched population is increased by 27% in the bone marrow
• however, no difference in bone marrow cellularity is seen
• analysis of LSK subsets shows an increase in the heterogenous progenitor cell population HPC-1
• however, the numbers of multipotent progenitor cells and HPC-2 populations are not different
• bone marrow cells from mutant mice repopulate the hematopoietic system of hosts more efficiently and retain stem cell capacity through serial transplantations
• enhanced hematopoietic reconstitution is due to increased production of differentiated progeny; HSCs show enhanced contribution to peripheral blood posttransplant and multipotent progenitor cells show enhanced contribution to peripheral leukocytes
• HSCs grown in culture show reduced proportion of self-renewing symmetric divisions and a trend toward higher proportion of differentiating divisions
• a reduced proportion of blast colonies and an increased proportion of differentiated colonies are produced from mutant bone marrow in vitro
• increase in the percentages of Ki67+ cycling cells within the HSC, HPC-1 and overall LSK populations and higher percentages of these cells incorporate BrdU
• however, no changes in cell death are seen in hematopoietic stem cells or progenitor populations

homeostasis/metabolism
• modest increase in IFN-alpha levels in the plasma
• however, no differences in IFN-gamma or other cytokine levels are seen

immune system
• mice show perturbation in early T-cell differentiation
• percentages of double-negative precursor stage 3 (DN3) cells are reduced but their total numbers are not significantly reduced
• mice have only 58% double-negative precursor stage 2 (DN2) cells compared with controls
• however, the numbers and percentages of downstream populations are not altered in the thymus
• numbers of plasmacytoid dendritic cells are increased in the bone marrow
• modest increase in IFN-alpha levels in the plasma
• however, no differences in IFN-gamma or other cytokine levels are seen

endocrine/exocrine glands
• mice have only 58% double-negative precursor stage 2 (DN2) cells compared with controls
• however, the numbers and percentages of downstream populations are not altered in the thymus

cellular
• increase in the percentages of Ki67+ cycling cells within the HSC, HPC-1 and overall LSK populations and higher percentages of these cells incorporate BrdU
• however, no changes in cell death are seen in hematopoietic stem cells or progenitor populations




Genotype
MGI:6507211
cn2
Allelic
Composition
Phf6tm1.1Avo/Y
Tg(Nes-cre)1Kln/0
Genetic
Background
involves: C57BL/6 * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Phf6tm1.1Avo mutation (1 available); any Phf6 mutation (12 available)
Tg(Nes-cre)1Kln mutation (4 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
growth/size/body
• reduction in body weight evident by 3 weeks of age, corresponding to a 43% reduction in body weight





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory